Macter International (KAR:MACTER) EBITDA Margin %: 0.00% (As of . 20)


KAR:MACTER Macter International Ltd KAR:MACTER
11 GF Score
Price ₨280.76
! 1 Warning Sign
View Full Analysis

What is Macter International EBITDA Margin %?

Macter International KAR:MACTER +2.40% 11 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates KAR:MACTER with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 954 Drug Manufacturers companies, Macter International ranks worse than 104821.7% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Macter International's EBITDA for the six months ended in . 20 was ₨0.00 Mil. Macter International's Revenue for the six months ended in . 20 was ₨0.00 Mil. Therefore, Macter International's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Macter International  (KAR:MACTER) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Macter International EBITDA Margin % Related Terms

Macter International EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Macter International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macter International EBITDA Margin % Chart

Macter International Annual Data
Trend
EBITDA Margin %

Macter International Semi-Annual Data
EBITDA Margin %

KAR:MACTER vs ZTS, UTHR, VTRS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Macter International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macter International EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Macter International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Macter International's EBITDA Margin % falls into.


KAR:MACTER
11GF Score
Macter International Ltd KAR:MACTER
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Macter International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Macter International's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Macter International's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Macter International (KAR:MACTER) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Macter International and its competitors. According to the industry distribution chart, Macter International ranks #999999 out of 954 companies in the Drug Manufacturers industry.
Is Macter International's EBITDA Margin % too high?
Macter International's current EBITDA Margin % is 0.00%. Based on the distribution chart, Macter International ranks #999999 out of 954 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Macter International has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Macter International's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Macter International ranks #999999 out of 954 companies for EBITDA Margin %. This places Macter International in the lower half of its industry. The industry median EBITDA Margin % is 12.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.52, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Macter International and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macter International's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macter International stock overvalued right now?
Macter International (KAR:MACTER) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Macter International's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Macter International (KAR:MACTER), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Macter International Business Description

Address F-216, SITE, Karachi, SD, PAK, 75700
Macter International Ltd is engaged in the manufacturing and marketing of pharmaceutical products and formulations for healthcare companies in Pakistan. It is covering almost all therapeutic categories including Antibiotics, Anti-allergy, cardiovascular, Anti-viral, and many more.
11GF Score

Get the complete analysis for KAR:MACTER

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨280.76
Price